Valeant's Xifaxan 'Gut Guy' gets noticed

CEO J. Michael Pearson isn't the only polarizing figure at Valeant ($VRX), apparently. Fans--and foes--of the company's new spokes-character "Gut Guy," the star of the drugmaker's new commercials for IBS-D med Xifaxan, are coming out in droves. On Twitter, Gut Guy has drawn a broad range of descriptors, from "disturbing" and "creepy" to "cute" and "cuddly." Valeant is likely just glad he's getting noticed at all; the company has socked more than $20 million into TV advertising since its push began in October. More from FiercePharmaMarketing